{"id":"https://openalex.org/W4389030924","doi":"https://doi.org/10.1093/ofid/ofad500.984","title":"1143. Meningococcal Vaccination Coverage Disparities in the United States: An Analysis with 2016-2021 National Immunization Survey-Teen Data","display_name":"1143. Meningococcal Vaccination Coverage Disparities in the United States: An Analysis with 2016-2021 National Immunization Survey-Teen Data","publication_year":2023,"publication_date":"2023-11-27","ids":{"openalex":"https://openalex.org/W4389030924","doi":"https://doi.org/10.1093/ofid/ofad500.984"},"language":"en","primary_location":{"id":"doi:10.1093/ofid/ofad500.984","doi":"https://doi.org/10.1093/ofid/ofad500.984","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofad500.984","pdf_url":"https://academic.oup.com/ofid/article-pdf/10/Supplement_2/ofad500.984/53768807/ofad500.984.pdf","source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://academic.oup.com/ofid/article-pdf/10/Supplement_2/ofad500.984/53768807/ofad500.984.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5015162886","display_name":"Oscar Herrera-Restrepo","orcid":"https://orcid.org/0000-0001-8193-999X","observed_orcids":["https://orcid.org/0000-0001-8193-999X"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Oscar Herrera-Restrepo","raw_affiliation_strings":["GSK , Philadelphia, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GSK , Philadelphia, Pennsylvania","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081710233","display_name":"Marta Kwiatkowska","orcid":"https://orcid.org/0000-0001-9022-7599","observed_orcids":["https://orcid.org/0000-0001-9022-7599"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marta Kwiatkowska","raw_affiliation_strings":["Evidera , London, England, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Evidera , London, England, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076725520","display_name":"Nelson Ndegwa","orcid":"https://orcid.org/0000-0001-5297-5107","observed_orcids":["https://orcid.org/0000-0001-5297-5107"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nelson Ndegwa","raw_affiliation_strings":["Evidera , London, England, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Evidera , London, England, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026603950","display_name":"Sara A. Poston","orcid":"https://orcid.org/0000-0003-4735-057X","observed_orcids":["https://orcid.org/0000-0003-4735-057X"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sara Poston","raw_affiliation_strings":["GSK , Philadelphia, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GSK , Philadelphia, Pennsylvania","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5047100651","display_name":"Michael Lee Ganz","orcid":"https://orcid.org/0000-0002-9702-2999","observed_orcids":["https://orcid.org/0000-0002-9702-2999"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Ganz","raw_affiliation_strings":["Evidera, Inc. , Waltham, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Evidera, Inc. , Waltham, Massachusetts","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3676,"currency":"USD","value_usd":3676},"apc_paid":{"value":3676,"currency":"USD","value_usd":3676},"fwci":0.5463,"has_fulltext":true,"cited_by_count":3,"citation_normalized_percentile":{"value":0.63219997,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":90,"max":96},"biblio":{"volume":"10","issue":"Supplement_2","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10873","display_name":"Bacterial Infections and Vaccines","score":0.9848999977111816,"subfield":{"id":"https://openalex.org/subfields/2404","display_name":"Microbiology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10873","display_name":"Bacterial Infections and Vaccines","score":0.9848999977111816,"subfield":{"id":"https://openalex.org/subfields/2404","display_name":"Microbiology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10833","display_name":"Vaccine Coverage and Hesitancy","score":0.014100000262260437,"subfield":{"id":"https://openalex.org/subfields/3306","display_name":"Health"},"field":{"id":"https://openalex.org/fields/33","display_name":"Social Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10146","display_name":"Cervical Cancer and HPV Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/meningococcal-vaccination","display_name":"meningococcal vaccination","score":0.9319999814033508},{"id":"https://openalex.org/keywords/menacwy-vaccine","display_name":"MenACWY vaccine","score":0.902999997138977},{"id":"https://openalex.org/keywords/menb-vaccine","display_name":"MenB vaccine","score":0.9380000233650208},{"id":"https://openalex.org/keywords/vaccination-coverage","display_name":"vaccination coverage","score":0.6600000262260437},{"id":"https://openalex.org/keywords/disparity","display_name":"disparity","score":0.37700000405311584},{"id":"https://openalex.org/keywords/adolescents","display_name":"adolescents","score":0.5519999861717224},{"id":"https://openalex.org/keywords/regional-variation","display_name":"regional variation","score":0.47099998593330383},{"id":"https://openalex.org/keywords/racial-and-ethnic-disparities","display_name":"racial and ethnic disparities","score":0.8560000061988831},{"id":"https://openalex.org/keywords/shared-decision-making","display_name":"shared decision-making","score":0.6779999732971191},{"id":"https://openalex.org/keywords/booster-vaccination","display_name":"booster vaccination","score":0.5740000009536743},{"id":"https://openalex.org/keywords/national-immunization-survey-teen","display_name":"National Immunization Survey-Teen","score":0.8690000176429749},{"id":"https://openalex.org/keywords/advisory-committee-on-immunization-practices-recommendations","display_name":"Advisory Committee on Immunization Practices recommendations","score":0.8970000147819519},{"id":"https://openalex.org/keywords/vaccine-hesitancy","display_name":"vaccine hesitancy","score":0.5899999737739563},{"id":"https://openalex.org/keywords/united-states","display_name":"United States","score":0.3580000102519989},{"id":"https://openalex.org/keywords/new-england","display_name":"New England","score":0.44999998807907104}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7281204462051392},{"id":"https://openalex.org/C2780801004","wikidata":"https://www.wikidata.org/wiki/Q1415366","display_name":"Immunization","level":3,"score":0.6363504528999329},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.6116585731506348},{"id":"https://openalex.org/C2780454893","wikidata":"https://www.wikidata.org/wiki/Q6817090","display_name":"Meningococcal vaccine","level":4,"score":0.5885618925094604},{"id":"https://openalex.org/C149923435","wikidata":"https://www.wikidata.org/wiki/Q37732","display_name":"Demography","level":1,"score":0.4754319190979004},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.46095895767211914},{"id":"https://openalex.org/C137403100","wikidata":"https://www.wikidata.org/wiki/Q41710","display_name":"Ethnic group","level":2,"score":0.4536263048648834},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.15945884585380554},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.10756289958953857},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.08011576533317566},{"id":"https://openalex.org/C144024400","wikidata":"https://www.wikidata.org/wiki/Q21201","display_name":"Sociology","level":0,"score":0.0},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1093/ofid/ofad500.984","doi":"https://doi.org/10.1093/ofid/ofad500.984","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofad500.984","pdf_url":"https://academic.oup.com/ofid/article-pdf/10/Supplement_2/ofad500.984/53768807/ofad500.984.pdf","source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10677981","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10677981","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10677981/pdf/ofad500.984.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infect Dis","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1093/ofid/ofad500.984","doi":"https://doi.org/10.1093/ofid/ofad500.984","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofad500.984","pdf_url":"https://academic.oup.com/ofid/article-pdf/10/Supplement_2/ofad500.984/53768807/ofad500.984.pdf","source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729},{"id":"https://metadata.un.org/sdg/10","display_name":"Reduced inequalities","score":0.7578999996185303}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4389030924.pdf","grobid_xml":"https://content.openalex.org/works/W4389030924.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4408627162","https://openalex.org/W3129771757","https://openalex.org/W4318042220","https://openalex.org/W4416168546","https://openalex.org/W3155471983","https://openalex.org/W2971175338","https://openalex.org/W4377564621","https://openalex.org/W7127622961","https://openalex.org/W7160901753","https://openalex.org/W2041122064"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"The":[2],"US":[3,47],"Advisory":[4],"Committee":[5],"on":[6,71],"Immunization":[7,67],"Practices":[8],"recommends":[9],"meningococcal":[10],"vaccination":[11,51,311],"against":[12,30],"serogroups":[13],"A,":[14],"C,":[15],"W,":[16],"and":[17,29,56,82,109,117,210,265,273,277,318,326],"Y":[18],"(MenACWY)":[19],"for":[20,34,105,118],"11\u201312":[21],"year-olds":[22],"(y/o)":[23],"with":[24,95,324,327],"a":[25,45,61],"booster":[26],"at":[27,122,357],"16;":[28],"serogroup":[31],"B":[32],"(MenB)":[33],"16\u201323":[35],"y/o":[36,133,147,161,181,198,216,233,240],"under":[37],"shared":[38],"clinical":[39],"decision":[40],"making":[41],"(SCDM).":[42],"We":[43,98],"used":[44],"large":[46],"survey":[48,69],"to":[49,138,152,166,186,192,205,221,275,292,300,360,364],"assess":[50],"coverage":[52,100,128,142,156,170,228,245,258,262,287,342,347],"across":[53,236,314],"vaccines,":[54,315],"geography":[55],"race/ethnicity.":[57],"Methods":[58],"This":[59],"was":[60,171,234],"cross-sectional":[62],"analysis":[63],"using":[64],"2016-2021":[65],"National":[66],"Survey-Teen":[68],"data":[70],"MenACWY":[72,79,106,119,127,141,176,193,227,244],"(\u22651":[73,84,107,111,129,143,157,177,212,229,253],"dose":[74],"[d])":[75],"in":[76,86,131,145,159,179,196,214,231,248,255,263,302,348,354],"13":[77,132,180,232],"y/o,":[78,257],"(\u22652":[80,120,194,246],"d)":[81,85,108,112,121,130,144,158,178,195,213,230,247,254],"MenB":[83,110,155,211,252,346],"17":[87,160,197,215,239,256],"y/o.":[88],"Data":[89],"were":[90],"collected":[91],"via":[92,367],"phone":[93],"interviews":[94],"provider":[96],"confirmation.":[97],"assessed":[99],"throughout":[101],"the":[102,114,123,358],"calendar":[103],"year":[104],"after":[113],"interview":[115,124],"date,":[116],"date.":[125],"Results":[126],"evolved":[134],"from":[135,149,163,175,271,290,298],"82.71%":[136],"(2016)":[137,151,165],"86.42%":[139],"(2021).":[140,154,168],"13-17":[146],"changed":[148,162],"83.36%":[150],"89.82%":[153],"5.63%":[164],"34.05%":[167],"Geographic":[169],"more":[172],"variable":[173],"moving":[174],"(74.44%":[182],"Pacific":[183,218],"region":[184,190,203,208,219,225],"2016":[185,204,220],"91.00%":[187],"New":[188],"England":[189],"2021)":[191,209],"(21.05%":[199],"East":[200],"South":[201,223],"Central":[202],"75.68%":[206],"Mid-Atlantic":[207],"(2.34%":[217],"45.29%":[222],"Atlantic":[224],"2021).":[226],"consistent":[235],"race/ethnicity,":[237],"while":[238,294],"Hispanic":[241,264],"had":[242],"lower":[243],"2021":[249],"(50.63%).":[250],"For":[251],"varied":[259],"by":[260],"race/ethnicity;":[261],"Non-Hispanic":[266],"(NH)":[267],"Black":[268],"populations":[269],"increased":[270,289],"5.55%":[272],"7.55%":[274],"33.58%":[276],"42.33%":[278],"over":[279],"5":[280],"years,":[281],"respectively.":[282],"In":[283],"NH":[284,304],"White":[285],"population,":[286],"yearly":[288],"5.29%":[291],"33.88%,":[293],"it":[295],"only":[296],"progressed":[297],"5.34%":[299],"27.17%":[301],"other":[303],"+":[305],"Multiple":[306],"race":[307],"population.":[308],"Conclusion":[309],"Meningococcal":[310],"disparities":[312],"persist":[313],"ages,":[316],"geography,":[317],"race/ethnicity":[319],"(MenB":[320,333],"only).":[321],"Disparities":[322],"increase":[323],"age,":[325],"SCDM-":[328],"versus":[329],"routinely-":[330],"recommended":[331],"vaccines":[332],"vs.":[334,351],"MenACWY).":[335],"Top":[336],"performing":[337],"states":[338],"show":[339],"that":[340],"better":[341],"is":[343],"possible":[344],"(\u223c70%":[345],"North":[349],"Dakota":[350],"34%":[352],"nationally":[353],"2021),":[355],"pointing":[356],"need":[359],"reduce":[361],"access":[362],"barriers":[363],"vaccination,":[365],"e.g.,":[366],"simplified":[368],"vaccine":[369],"recommendations/schedules.":[370],"Disclosures":[371],"Oscar":[372],"Herrera-Restrepo,":[373],"PhD,":[374],"GSK:":[375,380],"Stocks/Bonds":[376,381],"Sara":[377],"Poston,":[378],"PharmD,":[379]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2}],"updated_date":"2026-10-29T09:56:32.521200","created_date":"2023-11-27T00:00:00"}